GLP1R and Alzheimer disease: Altogether, our results constitute a first approach to disentangle the complex puzzle underlying the use of the GLP-1 mimetic liraglutide as a potential preventive/therapeutic agent against some of the earlier AD-like pathological signs in female mice.